UBS Maintains Neutral on Xponential Fitness, Lowers Price Target to $4.5

Benzinga Newsdesk www.benzinga.com Negative 61.8%

Neg 61.8% Neu 0% Pos 0%

UBS analyst Arpine Kocharyan maintains Xponential Fitness (NYSE:XPOF) with a Neutral and lowers the price target from $7 to $4.5.